Weight loss injections with gallstones: what you need to ask before starting

Do gallstones stop you using weight loss injections?

This is the question most people arrive with, and the short answer is: not necessarily. Neither Mounjaro (tirzepatide) nor Wegovy (semaglutide) list gallstones as an absolute contraindication in their UK-approved prescribing information. What both SmPCs do list is cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) among known side effects, meaning these conditions can arise or worsen on treatment, not merely that they are disqualifying beforehand.

The distinction matters. If your gallstones have been silent for years and your gallbladder is otherwise healthy, many prescribers will consider treatment appropriate with careful monitoring. If you have had repeated episodes of biliary colic, a recent acute attack, or active cholecystitis, your prescriber may want to speak with your GP or specialist first, or recommend that your gallbladder situation is settled before starting.

There is a persistent misconception that any abdominal history is a flat no. That is not how the guidance reads. The clinical judgement turns on the severity and recency of your gallbladder symptoms, your overall risk profile, and what you are hoping treatment will achieve. Our overview of who can use weight loss injections sets out the broader eligibility picture for context.

Why does rapid weight loss make gallstones more likely?

When body fat breaks down quickly, the liver secretes more cholesterol into bile than the gallbladder can keep in solution. Cholesterol crystals can then precipitate and, over weeks, consolidate into stones. This is not unique to GLP-1 medicines, it has been documented after bariatric surgery, very-low-calorie diets, and any intervention that produces weight loss faster than roughly 1–1.5 kg per week.

GLP-1 receptor agonists slow gastric emptying and reduce appetite, which typically produces a more gradual calorie deficit than crash dieting. That pacing is thought to reduce (though not remove) the gallstone-formation risk compared with very rapid methods. The relationship between weight loss injections and gallstone formation is explored in more detail on a dedicated page if you want the full picture.

The NHS notes gallbladder problems as a side effect to watch for during GLP-1 treatment. The practical implication: if you develop severe pain under the right side of your ribs, particularly after eating fatty food, that radiates to your shoulder or back, you should seek prompt medical attention rather than waiting for your next scheduled review. This applies whether or not you have had gallstones before.

What will a prescriber actually ask about your gallbladder history?

Before any GLP-1 prescription is issued, a thorough clinical assessment covers your full medical history. Where gallstones are concerned, the questions that matter most are: are yours currently symptomatic? Have you had cholecystitis, pancreatitis, or a procedure on your gallbladder? The connection between gallstones and pancreatitis is clinically relevant here, gallstones are among the most common causes of acute pancreatitis, and in January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious potential side effect of GLP-1 medicines. A history of gallstone-related pancreatitis is therefore a flag that warrants particularly careful prescriber review.

You should also mention if your gallbladder has already been removed. Cholecystectomy does not prevent GLP-1 treatment, it simply changes the risk profile, since bile can no longer pool and concentrate in the same way. Our clinical team follows the same assessment process for every patient: a named GPhC-registered prescriber reads your history personally on the same day you submit your consultation. If you are weighing up whether your specific gallstone history affects your suitability, our dedicated page on whether you can take weight loss injections with gallstones walks through the key considerations in detail. There is also separate guidance on kidney stones and weight loss injections for anyone managing both conditions at once.

How to approach treatment safely if you have a gallstone history

Assuming your prescriber considers treatment appropriate, a few practical things can help you monitor your gallbladder health while on a GLP-1 medicine. First, be consistent about reporting any new or worsening abdominal symptoms at your aftercare reviews, do not assume discomfort is just a standard GI side effect of the medicine. Second, your prescriber may recommend a slower titration schedule to keep the pace of weight loss measured; the standard titration on both Mounjaro and Wegovy already starts at a low dose and moves in gradual steps for exactly this tolerability reason.

Diet during treatment also plays a role. Very high-fat meals stimulate the gallbladder to contract sharply, which can trigger symptoms if a stone is present. Most people on GLP-1 treatment find their appetite for heavy, fatty food reduces naturally, but it is worth being conscious of this during the early weeks. The NHS's patient information for tirzepatide includes gallbladder problems in the list of side effects to watch for and advises contacting a doctor promptly if they occur.

If you are at the point of deciding whether to explore treatment, looking at the full range of licensed weight loss injections available in the UK can help you understand the options before your consultation. And if you have already decided and want to know where to access weight loss injections safely, that page covers what to look for in a legitimate, regulated provider. For a broader view of treatment pathways alongside lifestyle support, the weight loss treatment overview is a useful starting point. A note on cost: treatment pricing, what is included, and how to think about value for a prescription medicine is covered on our treatments page.